Posted on April 25th, 2012, 9:54 pm
GenomeWeb In Lancet Oncology this week, researchers in China report on the efficacy of gefitinib as a maintenance therapy for patients with locally advanced or metastatic non-small-cell lung cancer. The team randomly assigned 296 patients to receive either ... |